Circulating Serum AGRN and ADAMTS8 With Related Candidates as Potential Biomarkers for Carotid Plaque Presence and Vulnerability
CNS Neuroscience & Therapeutics · 2026-09 · 32 (9)
DOI: 10.1002/cns.71130 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 16.09.2026. Verfasst von Shuaiwei Guo und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Xuanwu Hospital, China International Neuroscience Institute; Capital Medical University, National Center for Neurological…. Hauptthemen laut MEDLINE: Agrin, Plaque, Atherosclerotic, ADAMTS Proteins, Carotid Artery Diseases. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Nova Program.
Abstract (Originalsprache)
Background
Carotid atherosclerosis is a major etiologic substrate for ischemic stroke. Although imaging can characterize stenosis and plaque morphology, circulating biomarkers may better support screening and scalable risk stratification, yet reliable serum protein markers for carotid plaque, particularly for plaque instability, remain limited.
Methods
We enrolled 128 participants, including patients with stable plaques ( n = 41), unstable plaques ( n = 49), and healthy controls ( n = 38). Plaque stability was determined by carotid ultrasonography. We prespecified a serum biomarker panel comprising seven proteins and measured all of them: agrin (AGRN), ADAMTS8, ADAMTS9, collagen type XVIII alpha 1 chain (COL18A1), integrin subunit beta 4 (ITGB4), lysyl oxidase like 4 (LOXL4), and slit guidance ligand 3 (SLIT3). All proteins were quantified by enzyme‐linked immunosorbent assay (ELISA). Group comparisons were performed with multiple‐comparison adjustment. Receiver operating characteristic (ROC) analyses and the area under the curve (AUC) evaluated the ability of individual biomarkers and the combined prediction probability to discriminate plaque presence and plaque instability.
Results
Baseline characteristics differed substantially between plaque groups and healthy controls. Serum AGRN concentrations were significantly elevated in plaque patients versus controls (mean ± SD, Stable: 2222.42 ± 508.30 pg/mL; Unstable: 2109.59 ± 513.51 pg/mL; Healthy: 1800.36 ± 375.89 pg/mL; overall p < 0.001), while ADAMTS8 levels were comparable across groups (overall p = 0.110). In multivariable Firth penalized logistic regression with log2‐transformed biomarkers, neither AGRN nor ADAMTS8 was independently associated with plaque presence or plaque instability after adjustment for age, sex, hypertension, alcohol use, dyslipidemia, smoking, diabetes mellitus, and coronary heart disease (all adjusted p > 0.05). For discriminating plaque presence, the combined AGRN+ADAMTS8 model achieved an apparent AUC of 0.771 (bootstrap 95% CI, 0.678–0.865; optimism‐corrected AUC, 0.764; repeated stratified 5‐fold cross‐validated AUC, 0.749). For plaque instability, the combined model showed no discriminatory capacity (apparent AUC, 0.549; optimism‐corrected AUC, 0.498; repeated 5‐fold cross‐validated AUC, 0.471).
Conclusions
Circulating AGRN and ADAMTS8, measured as serum concentrations, are associated with carotid plaque presence versus healthy controls but do not independently discriminate plaque presence or instability after multivariable adjustment. Clinical covariates alone (age, sex, vascular risk factors) provided near‐perfect discrimination of plaque presence, indicating substantial spectrum bias arising from the healthy‐control comparator design. These findings underscore the need for age‐ and risk‐matched comparator populations in future biomarker studies, consistent with STARD 2015 recommendations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Xuanwu Hospital, China International Neuroscience Institute; Capital Medical University, National Center for Neurological Disorders, Beijing, China.
- First Hospital, Peking University, Beijing, China.
- Health Science Center, Peking University, Beijing, China.
- Emergency of Neurosurgery, Affiliated Hospital of Shandong Second Medical University, Shandong, China.
- Department of Neurosurgery, North China University of Science and Technology Affiliated Hospital/North China University of Science and Technology, Tangshan, China.
- Department of Interventional Neuroradiology, Xuanwu Hospital, China International Neuroscience Institute; Capital Medical University, National Center for Neurological Disorders, Beijing, China.
ORCID-Profile: Xiao Zhang, Zixuan Xing, Jiaqi Jin, Liqun Jiao, Tao Wang
Förderung
- National Natural Science Foundation of China
- Beijing Nova Program
Zitieren
APA
Guo, S., Cui, S., Zhang, X., Xing, Z., Sun, Y., Qin, M., Ma, X., Li, X., Ma, Y., Gao, P., Chen, Y., Wang, Y., Yang, B., Chen, J., Chen, F., Lu, X., Jin, J., Jiao, L., & Wang, T. (2026). Circulating Serum AGRN and ADAMTS8 With Related Candidates as Potential Biomarkers for Carotid Plaque Presence and Vulnerability. CNS Neuroscience & Therapeutics, 32(9). https://doi.org/10.1002/cns.71130
Vancouver
Guo S, Cui S, Zhang X, Xing Z, Sun Y, Qin M, et al. Circulating Serum AGRN and ADAMTS8 With Related Candidates as Potential Biomarkers for Carotid Plaque Presence and Vulnerability. CNS Neuroscience & Therapeutics. 2026;32(9). doi:10.1002/cns.71130
BibTeX
@article{Guo2026,
author = {Guo, Shuaiwei and Cui, Shengyan and Zhang, Xiao and Xing, Zixuan and Sun, Yixin and Qin, Mingqian and Ma, Xiaoying and Li, Xiangyu and Ma, Yan and Gao, Peng and Chen, Yanfei and Wang, Yabing and Yang, Bin and Chen, Jian and Chen, Fei and Lu, Xia and Jin, Jiaqi and Jiao, Liqun and Wang, Tao},
title = {Circulating Serum AGRN and ADAMTS8 With Related Candidates as Potential Biomarkers for Carotid Plaque Presence and Vulnerability},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {9},
doi = {10.1002/cns.71130}
}
EUVIMED